97 related articles for article (PubMed ID: 709539)
21. Serum copper investigations in children with acute lymphoblastic leukemia.
Legutko L
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(2):248-54. PubMed ID: 79530
[TBL] [Abstract][Full Text] [Related]
22. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR).
Lazarus HM; Loberiza FR; Zhang MJ; Armitage JO; Ballen KK; Bashey A; Bolwell BJ; Burns LJ; Freytes CO; Gale RP; Gibson J; Herzig RH; LeMaistre CF; Marks D; Mason J; Miller AM; Milone GA; Pavlovsky S; Reece DE; Rizzo JD; van Besien K; Vose JM; Horowitz MM
Bone Marrow Transplant; 2001 Feb; 27(4):387-96. PubMed ID: 11313668
[TBL] [Abstract][Full Text] [Related]
23. Electron spin resonance as a useful technique in the management of Hodgkin's disease.
Foster M; Fell L; Pocklington T; Akinsete F; Dawson A; Hutchison JM; Mallard JR
Clin Radiol; 1977 Jan; 28(1):15-22. PubMed ID: 192508
[TBL] [Abstract][Full Text] [Related]
24. Metabolic changes in red blood cells in malignant lymphomas.
De Bellis R; Boulard MR; Kasdorf H; Rodriguez I; Ferrando R; Di Landro J; Ferrari M; Sanguinett CM; Tanzer J
Br J Haematol; 1979 May; 42(1):35-9. PubMed ID: 465359
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostics of relapse in hodgkin's disease (author's transl)].
Dietzel F; Grebe SF; Ristig W; Schmidt HG; Steckenmesser R
Med Klin; 1974 Feb; 69(7):289-92. PubMed ID: 4363084
[No Abstract] [Full Text] [Related]
26. Therapeutic implications and sites of relapse predicted by elevated posttherapy erythrocyte sedimentation rate in early stage Hodgkin disease.
Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
Am J Hematol; 1991 Aug; 37(4):253-7. PubMed ID: 1858782
[TBL] [Abstract][Full Text] [Related]
27. [Influence of age on treatment results in children and adolescents with Hodgkin's disease].
Balwierz W; Moryl-Bujakowska A; Depowska T; Klekawka T; Stanuch H; Matysiak M; Sopyło B; Kołakowska-Mrozowska B; Krenke K; Chybicka A; Raś M; Sońta-Jakimczyk D; Moszant A; Wachowiak J; Kaczmarek-Kanold M; Kowalczyk J; Odój T; Balcerska A; Drozyńska E; Wysocki M; Kołtan A; Krawczuk-Rybak M; Stolarska M
Przegl Lek; 2004; 61 Suppl 2():40-4. PubMed ID: 15686044
[TBL] [Abstract][Full Text] [Related]
28. Serum copper level in non-Hodgkin's lymphomas.
Salvagno L; Pappagallo GL; Chiarion Sileni V; Segati R; Cartei G; Endrizzi L; Paccagnella A; Ongaro G; Bonvicini P; Fiorentino MV
Tumori; 1982 Feb; 68(1):57-62. PubMed ID: 7071946
[TBL] [Abstract][Full Text] [Related]
29. New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.
Josting A; Franklin J; May M; Koch P; Beykirch MK; Heinz J; Rudolph C; Diehl V; Engert A
J Clin Oncol; 2002 Jan; 20(1):221-30. PubMed ID: 11773173
[TBL] [Abstract][Full Text] [Related]
30. Malignant lymphoma: monitoring of tumour status in 273 patients using a monoclonal antibody, 'B5', reacting with autologous erythrocytes.
Bruce L; Hancock BW; Cawood L
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):719-22. PubMed ID: 3653191
[TBL] [Abstract][Full Text] [Related]
31. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
Dann EJ; Daugherty CK; Larson RA
Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
[TBL] [Abstract][Full Text] [Related]
32. The erythrocyte sedimentation rate as a monitor for relapse in patients with previously treated Hodgkin's disease.
Le Bourgeois JP; Tubiana M
Int J Radiat Oncol Biol Phys; 1977; 2(3-4):241-7. PubMed ID: 863759
[No Abstract] [Full Text] [Related]
33. [Serum copper and zinc levels in patients with malignant neoplasm of the urogenital tract].
Sanada S; Ogura K; Kiriyama T; Yoshida O
Hinyokika Kiyo; 1985 Aug; 31(8):1299-316. PubMed ID: 4083194
[TBL] [Abstract][Full Text] [Related]
34. Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease.
Wagener DJ; Haanen C
Eur J Clin Invest; 1977 Aug; 7(4):289-94. PubMed ID: 408150
[TBL] [Abstract][Full Text] [Related]
35. Prognostic importance of serum transferrin and ferritin in childhood Hodgkin's disease.
Hann HW; Lange B; Stahlhut MW; McGlynn KA
Cancer; 1990 Jul; 66(2):313-6. PubMed ID: 2369713
[TBL] [Abstract][Full Text] [Related]
36. Serum copper levels in non-Hodgkin's lymphoma.
Shah-Reddy I; Khilanani P; Bishop CR
Cancer; 1980 Apr; 45(8):2156-9. PubMed ID: 6989485
[TBL] [Abstract][Full Text] [Related]
37. Nucleoli in lymphocytes of the peripheral blood in Hodgkin's disease: I. Changes in the course of the disease.
Dientsbier Z; Foltýnová V; Rezný Z; Vĕtrovcová E
Czech Med; 1978; 1(3):142-52. PubMed ID: 699718
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the prognostic meaning of C-reactive protein (CRP) in children and adolescents with classical Hodgkin's lymphoma (HL).
Haase R; Vilser C; Mauz-Körholz C; Hasenclever D; Kluge R; Ruschke K; Borkhardt A; Seeger K; Lehrnbecher T; Kulozik A; Rößler J; Burdach S; Jürgens H; Körholz D
Klin Padiatr; 2012 Oct; 224(6):377-81. PubMed ID: 23047832
[TBL] [Abstract][Full Text] [Related]
39. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
40. The erythrocyte sedimentation rate. Still a helpful test when used judiciously.
Brigden M
Postgrad Med; 1998 May; 103(5):257-62, 272-4. PubMed ID: 9590999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
